ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 130 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2024. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,862,990 | -72.7% | 926,534 | -77.2% | 0.03% | -72.2% |
| Q1 2024 | $10,502,300 | -11.0% | 4,070,659 | -13.8% | 0.10% | -24.2% |
| Q4 2023 | $11,799,758 | +23.2% | 4,719,903 | 0.0% | 0.13% | +14.3% |
| Q3 2023 | $9,581,403 | +68.7% | 4,719,903 | +91.2% | 0.11% | +67.2% |
| Q2 2023 | $5,679,153 | -29.5% | 2,469,197 | -7.1% | 0.07% | -39.1% |
| Q1 2023 | $8,052,543 | +278.2% | 2,657,605 | +435.6% | 0.11% | +214.3% |
| Q3 2021 | $2,129,000 | +715.7% | 496,172 | +533.4% | 0.04% | +483.3% |
| Q1 2021 | $261,000 | – | 78,339 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 12,862,152 | $33,184,352 | 20.21% |
| FourWorld Capital Management LLC | 3,000,527 | $7,741,360 | 4.94% |
| Two Seas Capital LP | 7,841,927 | $20,232,172 | 3.96% |
| Corbin Capital Partners, L.P. | 853,304 | $2,201,524 | 3.72% |
| BlackBarn Capital Partners LP | 2,070,900 | $5,342,922 | 3.02% |
| FourWorld Capital Management LLC | 1,570,000 | $4,050,600 | 2.58% |
| ADAR1 Capital Management, LLC | 2,074,183 | $5,351,392 | 1.21% |
| Woodline Partners LP | 4,070,659 | $10,502,300 | 0.10% |
| Centiva Capital, LP | 1,352,880 | $3,490,430 | 0.08% |
| Hudson Bay Capital Management LP | 3,520,382 | $9,082,586 | 0.05% |